Valuation : Simcere Pharmaceutical Group Limited

Market Cap 3.64B 28.5B 3.13B 2.94B 2.68B 5.04B 346B 5.08B 34.83B 13.55B 175B 13.65B 13.36B 581B P/E 2026 *
13.9x
P/E 2027 * 12.1x
Enterprise Value 3.44B 26.96B 2.96B 2.78B 2.54B 4.77B 327B 4.8B 32.94B 12.82B 166B 12.91B 12.63B 549B EV / Sales 2026 *
2.29x
EV / Sales 2027 * 2.07x
Free-Float
32.13%
Yield 2026 *
3.78%
Yield 2027 * 4.3%
1 day-1.77%
1 week-8.11%
Current month-10.12%
1 month-11.27%
3 months+11.33%
6 months-6.17%
Current year-7.27%
1 week 11.02
Extreme 11.02
11.79
1 month 11.02
Extreme 11.02
12.82
Current year 9.07
Extreme 9.07
14.28
1 year 9.07
Extreme 9.07
14.55
3 years 4.94
Extreme 4.94
15.08
5 years 4.94
Extreme 4.94
15.08
10 years 4.94
Extreme 4.94
15.08
Manager TitleAgeSince
Chief Executive Officer 63 20/08/2026
Chief Executive Officer 54 25/03/2026
Director of Finance/CFO 55 19/11/2019
Director TitleAgeSince
Chairman 63 08/10/2012
Director/Board Member 55 19/11/2019
Director/Board Member 46 01/11/2019
Date Insider Type Main position Quantity % Market Cap. Importance
20/8/26 Other

Chairperson

-3,000,000 0.1168%
13/7/26 Other

Founder

-47,000 0.0018%
13/7/26 Other

Director

-47,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
-1.77%-8.11%-21.39%+77.60% 3.7B
+3.38%+4.33%+24.48%+78.02% 48.2B
+0.66%+0.45%+57.74%+122.48% 39.97B
-2.49%+3.69%+18.37%+84.89% 12.43B
-1.00%-1.61%-11.34%+14.00% 12.03B
+0.19%0.00%+29.35%+150.00% 9.35B
-1.80%-1.50%+25.41%+48.78% 7.75B
-1.39%+6.99%+28.90%+228.32% 7.43B
-0.26%+0.10%+47.89%-11.58% 7.22B
-0.84%-2.36%-36.62%+16.04% 5.3B
Average -0.53%+1.26%+16.28%+80.86% 15.34B
Weighted average by Cap. +0.72%+1.17%+28.28%+88.96%

Financials

2026 *2027 *
Net sales 1.5B 11.77B 1.29B 1.21B 1.11B 2.08B 143B 2.1B 14.38B 5.6B 72.43B 5.64B 5.51B 240B 1.69B 13.26B 1.46B 1.37B 1.25B 2.35B 161B 2.36B 16.21B 6.31B 81.64B 6.35B 6.21B 270B
Net income 255M 2B 220M 206M 188M 354M 24.29B 356M 2.45B 951M 12.32B 958M 938M 40.78B 302M 2.36B 260M 244M 223M 418M 28.7B 421M 2.89B 1.12B 14.55B 1.13B 1.11B 48.19B
Net Debt -197M -1.55B -170M -160M -146M -274M -18.77B -275M -1.89B -735M -9.52B -741M -725M -31.52B -140M -1.1B -120M -113M -103M -194M -13.3B -195M -1.34B -521M -6.74B -525M -513M -22.32B
Logo Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces various drugs, including Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions. The Company mainly conducts its businesses in the domestic market and overseas markets.
Employees
7,064
Date Price Change Volume
31/08/26 HKD 11.10 -1.77% 7,703,000
28/08/26 HKD 11.30 -1.82% 4,726,000
27/08/26 HKD 11.51 -0.78% 4,617,000
26/08/26 HKD 11.60 +0.61% 5,882,000
25/08/26 HKD 11.53 -0.60% 5,952,643
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
9.525CNY
Average target price
15.11CNY
Spread / Average Target
+58.65%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2096 Stock